Health Products

AXID (2020-04-29)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

AXID 150 mg Capsules

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
616927, 617088
Recalling Firm
Pendopharm Division of Pharmascience Inc.
SUITE 100 6111, Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pendopharm Division of Pharmascience Inc.
SUITE 100 6111, Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
AXID 150 mg CapsulesDIN 00778338CapsuleNizatidine 150 mg

Reason

Presence of N-nitrosodimethylamine (NDMA) near the interim acceptable concentration limit in affected lots

Depth of distribution

Wholesalers, Retailers, Healthcare establishments

For more information

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime